←News detail

People's DailyUpdated Oct 28 09:43

Zhang Boli's team and Yangzijiang Pharmaceutical release a large AI model for testing Chinese medicinal herbs

English text is being prepared.

AI summary

The large AI model for testing Chinese medicinal herbs, jointly developed by Zhang Boli's team and Yangzijiang Pharmaceutical Group, was officially released, and an intelligent testing device equipped with this technology was unveiled at the same time; a single sample test takes only a few dozen seconds. The device integrates industrial vision, hyperspectral analysis and X-ray transmission imaging, and its comprehensive testing accuracy can reach over 90%. Modeling has been completed for more than 50 commonly used Chinese medicinal herbs, covering bulk varieties prone to adulteration such as gardenia, ginseng, angelica, red ginseng and astragalus. The team said that AI testing does not replace statutory inspection and professional judgment, and that in the future it will iterate portable versions to extend down to production areas and markets.

Body

10月16日,江西樟树岐黄小镇会展中心,一颗颗栀子被送进检测设备,自动上料设备将其送入舱内,工业视觉系统扫描外观,X光透视内部,高光谱分析成分——几十秒后,一份数字化的“体检报告”生成。

当日,第五十七届全国药材药品交易会在樟树开幕,由中国工程院院士张伯礼团队与扬子江药业集团协同研发的AI(人工智能)中药材检测大模型正式发布,搭载该技术的智能检测设备同步亮相。

中药材品质判定长期依赖药工“眼观、手摸、鼻闻、口尝”,感官描述缺乏统一量化指标,不同师傅、不同批次判断常有差异。而且人工看货耗时长,实验室理化检测前处理复杂、等待时间以小时甚至天计算,而药材交易却是批量、多批次、高频次的现场作业,人工看货影响工作效率。

中药材品种多、来源广,真伪难分、优劣难辨,叠加流通链条长、全程溯源难等问题,标准化建设不够和高级别循证证据不足仍是问题,“标准不少、用得不多”的现象普遍存在。

这套智能检测设备以专属多模态AI大模型为主导,融合工业视觉、高光谱分析和X光穿透成像三大技术。工业视觉识别形态、色泽和纹理,辅助发现外观异常及表面异物;高光谱分析为成分含量估测、品质分级和真伪鉴别提供参考;X光透视内部,识别空洞、虫蛀等结构异常。3类信号一并交给大模型,大模型“阅读”大量合格与掺伪样本,可综合判断中药材优劣。

设备进行单样检测只需几十秒,无需复杂制样。药材到货,取样入舱即出结果——入库质检据此判断有无掺伪、变质,不合格当场拒收,不必空等;产线上随机抽样,混入伪品、出现霉变及时预警,避免整批报废;交易市场收药当场测,买卖双方同步看到结果,减少“凭经验看货”带来的纠纷。

天津现代创新中药科技有限公司高级经理刘长青介绍,该设备综合检测准确率可达90%以上,已完成50余种常用中药材建模,覆盖栀子、人参、当归、红参、黄芪等易掺伪的大宗品种。

刘长青介绍,AI检测不替代法定检验和专业人员判断。它把老药工摸其质、拈其重、观其形、尝其味、嗅其气的本领,沉淀为可调用、可追溯的数据资产:检测中的图片、光谱、判定结果自动保存,形成药材从收买到进厂的电子档案,既能做来料台账、质量复盘,也可对接监管溯源平台。更重要的是,AI检测把“颜色、质地、外观优劣”转化为可量化指标,助力道地药材数字化标准落地。

与此同时,农药残留、重金属微量化学成分,仅靠视觉加高光谱难以精准定量,团队正研究多技术融合方案以实现突破。此外,设备未来将迭代便携版本,下沉到产地和市场。

Source

People's Daily